MGMT methylation pattern of long-term and short-term survivors of glioblastoma reveals CpGs of the enhancer region to be of high prognostic value.

MLA

Leske, Henning, et al. “MGMT Methylation Pattern of Long-Term and Short-Term Survivors of Glioblastoma Reveals CpGs of the Enhancer Region to Be of High Prognostic Value.” Acta Neuropathologica Communications, vol. 11, no. 1, Aug. 2023, pp. 1–12. EBSCOhost, https://doi.org/10.1186/s40478-023-01622-w.

APA

Leske, H., Camenisch Gross, U., Hofer, S., Neidert, M. C., Leske, S., Weller, M., Lehnick, D., & Rushing, E. J. (2023). MGMT methylation pattern of long-term and short-term survivors of glioblastoma reveals CpGs of the enhancer region to be of high prognostic value. Acta Neuropathologica Communications, 11(1), 1–12. https://doi.org/10.1186/s40478-023-01622-w

Chicago

Leske, Henning, Ulrike Camenisch Gross, Silvia Hofer, Marian Christoph Neidert, Sabine Leske, Michael Weller, Dirk Lehnick, and Elisabeth Jane Rushing. 2023. “MGMT Methylation Pattern of Long-Term and Short-Term Survivors of Glioblastoma Reveals CpGs of the Enhancer Region to Be of High Prognostic Value.” Acta Neuropathologica Communications 11 (1): 1–12. doi:10.1186/s40478-023-01622-w.